13-GI-90-LP TELEPATH: Long term extension study of telotristat (LX1606)

Grants and Contracts Details

StatusFinished
Effective start/end date1/13/1410/28/18

Funding

  • Lexicon Pharmaceuticals Incorporated: $193,209.00